TransCode Therapeutics - SEC Filing

Por um escritor misterioso

Descrição

Technical Analysis of TransCode Therapeutics, Inc. (NASDAQ:RNAZ

MRC Global Announces Proposed Refinan

EDGAR Filing Documents for 0001104659-21-029169

TransCode Therapeutics - SEC Filing

EDGAR Filing Documents for 0001104659-21-029169

TransCode Therapeutics - SEC Filing

Oncology biotech Transcode Therapeutics files for a $30 million

TransCode Therapeutics, Inc. Announces Pricing of Initial Public

TransCode Therapeutics Manhattan Street Capital

EDGAR Filing Documents for 0001104659-21-029169

de por adulto (o preço varia de acordo com o tamanho do grupo)

Sugerir pesquisas